Abstract: . . .  Jennifer L Gu, California Institute of Technology, Pasadena, CA; Lawrence W Castellani, Aldons J Lusis, University of California Los Angeles, Los Angeles, CA ATP Binding and Hydrolysis are P100 Required but not Sufficient for ABCA1-Mediated Cholesterol Redistribution Chongren Tang, Ashley M Vaughan, Jhon F Oram, University of Washington, Seattle, WA Amyloid-Beta Peptide in P101 Atherogenesis: A Novel Role beyond Alzheimers Disease Ling Li, Hongquan Wan, Dongfeng Cao, Ken-Ichiro Fukuchi, Univ of Alabama at Birmingham, Birmingham, AL Macrophage-Specific Expression of P102 Paraoxonase-1 via Stem Cell Replacement Reduces Atherosclerosis Alejandra Gutierrez, Jon H Miyake, San Diego State U . . .
. . .  Janigro, The Cleveland Clinic Foundation, Cleveland, OH 11:00 Moderate Doses of Recombinant 33 Tissue Plasminogen Activator Equalize the Activities of Matrix Metalloproteinases and Their Inhibitors Dorothe Burggraf, Helge K Martens, Gerhard F Hamann, Ludwig-Maximilians-University, Munich, Germany 11:15 Angiogenesis and Skeletal Development & Repair Jill Helms, San Francisco, CA 11:45 Lunch break on your own Plenary Session IV 1:30 PM 3:00 PM Continental Ballroom 45 Moderators John D. Brunzell, Seattle, WA Lawrence L. Rudel, Winston-Salem NC 1:30 Jeffrey M. Hoeg Arteriosclerosis , Thrombosis and Vascular Biology Award for Basic Science and Clinical Research Lecture: Insights into the Metabolic Syndrome from Human Genetics Robert A. Hegele, London, ON, Canada 2:00 Cellular Abnormalities of Angiogenic Blood Vessels Donald M. McDonald, San Francisco, CA 2:30 Point Counterpoint: Big vs Small LDL - Which Are More Atherogenic? Lawrence L. Rudel, Winston-Salem, NC John D. Brunzell, Seattle, WA 3:00 Refreshment Break 9 FRID A Y Page 12 Concurrent Session IV 3:30 PM 5:15 PM Session A . . .
--3000,2,750,2478,64535